Klinik Araştırma

Is the use of first-trimester systemic inflammation markers predictive in fetal growth restriction?

Cilt: 22 Sayı: 1 22 Mart 2025
PDF İndir
TR EN

Is the use of first-trimester systemic inflammation markers predictive in fetal growth restriction?

Öz

Aim: To predict fetal growth restriction (FGR) and its effect on prognosis according to changes in systemic inflammation indexes, such as the neutrophil-to-lymphocyte ratio (NLR), the systemic immune-inflammation index (SII), and the systemic inflammation response index (SIRI). Materials and Methods: The study group consisted of 200 women with singleton pregnancies diagnosed with FGR, and the control group comprised 280 obstetrically and demographically matched healthy pregnant women. The NLR, SII, and SIRI were compared between the groups according to the first-trimester complete blood count results. Results: When the groups were compared in terms of systemic inflammation indexes, the NLR, SII, and SIRI were found to be statistically lower in the FGR group (p<0.001, p=0.01, and p=0.03, respectively). Conclusion: We found that the NLR, SII, and SIRI were lower in pregnant women with FGR compared to the control group, according to the first-trimester complete blood count analysis.

Anahtar Kelimeler

Etik Beyan

The study was approved by the Medical Research Ethics Unit of the hospital (E2-22-2848).

Kaynakça

  1. Fetal Growth Restriction: ACOG Practice Bulletin, Number 227. Obstet Gynecol. 2021;137(2):e16-e28. Chauhan SP, Rice MM, Grobman WA, Bailit J, Reddy UM, Wapner RJ, et al. Neonatal Morbidity of Small- and Large-for-Gestational-Age Neonates Born at Term in Uncomplicated Pregnancies. Obstet Gynecol. 2017;130(3):511-9. Albu AR, Anca AF, Horhoianu VV, Horhoianu IA. Predictive factors for intrauterine growth restriction. J Med Life. 2014;7(2):165-71. Schjenken JE, Green ES, Overduin TS, Mah CY, Russell DL, Robertson SA. Endocrine Disruptor Compounds-A Cause of Impaired Immune Tolerance Driving Inflammatory Disorders of Pregnancy? Front Endocrinol (Lausanne). 2021;12:607539.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Kadın Hastalıkları ve Doğum

Bölüm

Klinik Araştırma

Yayımlanma Tarihi

22 Mart 2025

Gönderilme Tarihi

3 Kasım 2024

Kabul Tarihi

20 Kasım 2024

Yayımlandığı Sayı

Yıl 2025 Cilt: 22 Sayı: 1

Kaynak Göster

APA
Ağaoğlu, Z., Tanacan, A., Denizli, R., Sakcak, B., Farisoğulları, N., Haksever, M., Kara, Ö., & Sahin, D. (2025). Is the use of first-trimester systemic inflammation markers predictive in fetal growth restriction? Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, 22(1), 7-11. https://doi.org/10.38136/jgon.1578631
AMA
1.Ağaoğlu Z, Tanacan A, Denizli R, vd. Is the use of first-trimester systemic inflammation markers predictive in fetal growth restriction? JGON. 2025;22(1):7-11. doi:10.38136/jgon.1578631
Chicago
Ağaoğlu, Zahid, Atakan Tanacan, Ramazan Denizli, vd. 2025. “Is the use of first-trimester systemic inflammation markers predictive in fetal growth restriction?”. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 22 (1): 7-11. https://doi.org/10.38136/jgon.1578631.
EndNote
Ağaoğlu Z, Tanacan A, Denizli R, Sakcak B, Farisoğulları N, Haksever M, Kara Ö, Sahin D (01 Mart 2025) Is the use of first-trimester systemic inflammation markers predictive in fetal growth restriction? Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 22 1 7–11.
IEEE
[1]Z. Ağaoğlu vd., “Is the use of first-trimester systemic inflammation markers predictive in fetal growth restriction?”, JGON, c. 22, sy 1, ss. 7–11, Mar. 2025, doi: 10.38136/jgon.1578631.
ISNAD
Ağaoğlu, Zahid - Tanacan, Atakan - Denizli, Ramazan - Sakcak, Bedri - Farisoğulları, Nihat - Haksever, Murat - Kara, Özgür - Sahin, Dilek. “Is the use of first-trimester systemic inflammation markers predictive in fetal growth restriction?”. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 22/1 (01 Mart 2025): 7-11. https://doi.org/10.38136/jgon.1578631.
JAMA
1.Ağaoğlu Z, Tanacan A, Denizli R, Sakcak B, Farisoğulları N, Haksever M, Kara Ö, Sahin D. Is the use of first-trimester systemic inflammation markers predictive in fetal growth restriction? JGON. 2025;22:7–11.
MLA
Ağaoğlu, Zahid, vd. “Is the use of first-trimester systemic inflammation markers predictive in fetal growth restriction?”. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, c. 22, sy 1, Mart 2025, ss. 7-11, doi:10.38136/jgon.1578631.
Vancouver
1.Zahid Ağaoğlu, Atakan Tanacan, Ramazan Denizli, Bedri Sakcak, Nihat Farisoğulları, Murat Haksever, Özgür Kara, Dilek Sahin. Is the use of first-trimester systemic inflammation markers predictive in fetal growth restriction? JGON. 01 Mart 2025;22(1):7-11. doi:10.38136/jgon.1578631